Negative Screening Results and Colorectal Cancer
This cohort study compares the long-term risk of colorectal cancer incidence and mortality among individuals receiving a negative colonoscopy screening result with those not undergoing endoscopy.
Related Articles
The Revision of the Declaration of Helsinki Viewed From the Americas
This Viewpoint explores the 2024 update to the Declaration of Helsinki from the perspective of the Americas and how countries in this region can implement…
Tailor-Made for a Lifelong Pursuit of Precision in Cancer Care
With a focus on closing gaps in cancer care for underserved populations, Joseph A. Sparano, MD, FACP, always strives to put patients first—a quality that…
Predicting Triple-Negative Breast Cancer Immunotherapy… : Oncology Times
An abstract is unavailable.
Revisiting the Declaration of Helsinki
This Viewpoint contextualizes the history of the Declaration of Helsinki, analyzes the implications of its latest revision, and emphasizes the need for patient-centricity in research…
Practical Guide to the Use of AI-Enabled Analytics in Research
This Guide to Statistics and Methods discusses approaches to incorporating artificial intelligence (AI)–enabled analytics when working with big data and outlines AI-related considerations for data…
Clinical Practice Insights Reveal the Complexity of Lymphoma Subtypes and Advances in First-Line Treatments: With Chandler Park, MD; and Joshua Brody, MD
Chandler Park, MD and Joshua Brody, MD discusses treatment challenges posed by the diverse spectrum of lymphomas, ranging from indolent subtypes, to aggressive diseases like…
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
Examining the AQUILA Trial Presented at ASH 2024
Panelists discuss how the AQUILA trial evaluated whether daratumumab monotherapy provides superior outcomes compared with active monitoring in high-risk smoldering multiple myeloma patients.
Patient-Centered Approaches in EGFR-Mutated NSCLC
Panelists discuss how oral and subcutaneous therapies have improved the quality of life for patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC), with Squires…
Ongoing Research Seeks to Optimize Targeted Therapy Use in mCRC
Aparna Parikh, MD, discussed novel agents that are currently at play in the mutated, metastatic colorectal cancer treatment field.